Status:
COMPLETED
Evaluate the Accuracy of a COPD Screening Algorithm Model
Lead Sponsor:
Peking University First Hospital
Collaborating Sponsors:
Civil Aviation General Hospital
Shichahai Community Health Service Center of Xicheng District Beijing
Conditions:
COPD
Eligibility:
All Genders
18+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, we have est...
Detailed Description
The investigators have established an algorithm that can detect COPD from physiological parameters, coughing sounds, and forceful expiratory sounds collected by wearable devices. This study will test ...
Eligibility Criteria
Inclusion
- Over the age of 18, no gender restrictions.
- Participants at high risk of COPD (COPD-PS score ≥5).
- Able to carry out daily activities and wear wearable devices.
- Willing to participate in the study, willing to comply with the study protocol, and have the ability to sign informed consent.
- Possess mobile communication equipment, which can meet the requirement of installing wearable device applications and recording function.
Exclusion
- Diagnosed with chronic respiratory diseases other than COPD, such as asthma, lung cancer, active tuberculosis, bronchiectasis and diffuse lung diseases (interstitial pneumonia, occupational lung disease, sarcoidosis, etc.).
- lobectomy and/or lung transplantation, pleural disease.
- Complicated with serious underlying diseases, including severe mental illness, intellectually impaired diseases, neurological disease (resulting in limb movement disorder), malignant tumor (PS score \> 2), chronic liver disease (transaminase \> 3 times the upper limit of normal), heart failure (NYHA\> Grade 3), autoimmune disease, chronic kidney disease (CKD-5), unstable coronary artery disease, arrhythmia (atrial fibrillation, atrial flutter, severe ventricular arrhythmia), congenital heart disease, pulmonary hypertension, etc., or life expectancy of less than 6 months.
- Malnutrition (BMI\<18 kg/m2).
- Bilateral wrist and hand edema, wrist soft tissue injury, inability to wear a watch/bracelet due to incomplete skin.
- Dual upper limb pigmentation or abnormal blood supply (occlusion, thrombosis, trauma, etc.).
Key Trial Info
Start Date :
September 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06109974
Start Date
September 13 2022
End Date
January 4 2024
Last Update
January 23 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Baizhifang Community Health Service Center of Xicheng District Beijing
Beijing, Beijing Municipality, China
2
Civil Aviation General Hospita
Beijing, Beijing Municipality, China
3
Guangfa Wang
Beijing, Beijing Municipality, China
4
Shichahai community health service center
Beijing, Beijing Municipality, China